The independent source for health policy research, polling, and news.
1,001-1,020 of 1,323 results
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump鈥檚 proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Last month, U.S. Surgeon General Jerome Adams聽urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
President Donald Trump鈥檚 much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children鈥檚 Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
Even voters who say they are more enthusiastic about voting in this congressional election than in past ones are not motivated by any specific issue. But, according to a poll out Thursday, health care policies rank high among topics voters want candidates to address.
A combination of factors has led to an 鈥渁stronomical鈥 increase in mentally ill inmates, followed by increased efforts to identify those who need prescriptions. Some say the meds are underprescribed; others, that they are given inappropriately, without the benefit of comprehensive treatment.
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
Denmark-based drugmaker Novo Nordisk has invested more in lobbying and doubled political donations since 2015.
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
President Donald Trump鈥檚 upcoming speech on drug prices comes after months of public comments and debate about tackling the issue.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Sarah Jane Tribble of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post examine how even after Republicans failed to repeal and replace the Affordable Care Act, the health care debate continues to roil politics. They discuss how Republicans in Congress have shifted their ACA messaging and how the Democrats are looking to Medicare expansion. They also discuss state efforts to expand Medicaid and drug pricing. And they spend a moment talking about Congress鈥 push to do something about the opioid crisis.
Surgeon General Jerome Adams urged more people to carry the drug naloxone, a lifesaving treatment for opioid overdoses. But this policy is tricky to implement.
Roughly half of patients don't take their high blood pressure medicine as they should, even though heart disease is the leading cause of death in America. Now, a drug test can flag whether a patient is taking the prescribed medication and is meant to spark a more truthful conversation between patient and doctor.
The decision in Maryland鈥檚 case could slow momentum for other states that are attempting to take action to curb high drug costs.
California and federal officials have cracked down on a major compounding pharmacy they say posed a threat to public safety, but their actions are worsening shortages of medications that doctors rely on to keep their patients out of pain.
漏 2026 KFF